Back to Search
THEODORE WASSERMAN, PH.D.
PH.D.
Clinical Child & Adolescent Psychologist
NPI: 1437296159Individual
Specialties, Licenses & Credentials
Clinical Child & Adolescent PsychologistPrimary
Psychologist — Clinical Child & Adolescent
Code: 103TC2200X
PY3977(FL)
Research & Publications (20)
The growth of academic radiation oncology: a survey of endowed professorships in radiation oncology.
PMID 19427550·Int J Radiat Oncol Biol Phys·2009
8-other
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
PMID 19018081·J Clin Oncol·2009
8-other
Balancing on a knife's edge: evidence-based medicine and the marketing of health technology.
PMID 18722261·Int J Radiat Oncol Biol Phys·2008
8-other
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
PMID 18501528·Int J Radiat Oncol Biol Phys·2008
8-other
Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
PMID 18474307·Int J Radiat Oncol Biol Phys·2008
8-other
A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).
PMID 18342381·Radiother Oncol·2008
3-trial
Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial.
PMID 16253773·Int J Radiat Oncol Biol Phys·2005
3-trial
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
PMID 15800308·J Clin Oncol·2005
3-trial
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
PMID 15337569·Int J Radiat Oncol Biol Phys·2004
6-review
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.
PMID 11917286·Semin Radiat Oncol·2002
3-trial
A prospective, nonrandomized study of the impact of amifostine on subsequent hypothyroidism in irradiated patients with head and neck cancers.
PMID 11917278·Semin Radiat Oncol·2002
7-preclinical
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
PMID 11777621·Int J Radiat Oncol Biol Phys·2002
8-other
Management of swallowing in supraglottic and extended supraglottic laryngectomy patients.
PMID 11774389·Head Neck·2001
8-other
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.
PMID 11709567·J Clin Oncol·2001
3-trial
Has the outlook improved for amifostine as a clinical radioprotector.
PMID 11570362·Radiother Oncol·2001
8-other
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.
PMID 11369065·Radiother Oncol·2001
3-trial
Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04.
PMID 11172943·Int J Radiat Oncol Biol Phys·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5325 GREENWOOD AVE, SUITE 201
WEST PALM BEACH, FL 33407 - Phone
- (561) 881-2822
Quick Facts
- NPI
- 1437296159
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile